Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

novanta - NOVT

NOVT

Close Chg Chg %
132.28 2.91 2.20%

Open Market

135.19

+2.91 (2.20%)

Volume: 51.99K

Last Updated:

Apr 21, 2026, 11:00 AM EDT

Trade Now

Company Overview: novanta - NOVT

NOVT Key Data

Open

$132.48

 Day Range

132.48 - 137.48

52 Week Range

98.27 - 148.68

 Market Cap

$4.72B

Shares Outstanding

35.68M

 Public Float

35.38M

Beta

1.65

 Rev. Per Employee

N/A

P/E Ratio

90.20

 EPS

$1.47

Yield

0.00%

 Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

312.07K

  

NOVT Performance

1 Week
 
 2.66%
 
1 Month
 
 16.19%
 
3 Months
 
 -4.07%
 
1 Year
 
 10.47%
 
5 Years
 
 -4.18%
 

NOVT Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 4
Full Ratings ➔

About novanta - NOVT

Novanta, Inc. engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Automation Enabling Technologies and Medical Solutions. The Automation Enabling Technologies segment enagages in the designing, manufacturing and marketing of laser beam steering and scanning solutions, laser sources, robotic and precision motion, robotic end-of-arm tooling, and bearing spindles to customers worldwide. The Medical Solutions segment is involved in the designing, manufacturing and marketing of medical grade technologies, including medical insufflators and endoscopic pumps and related disposables, imaging, identification and RFID solutions, advanced motion control solutions, light engines, and integrated operating room technologies. The company was founded in 1968 and is headquartered in Bedford, MA.

NOVT At a Glance

Novanta, Inc.
125 Middlesex Turnpike
Bedford, Massachusetts 01730-1409
Phone 1-781-266-5700 Revenue 980.60M
Industry Electronic Equipment/Instruments Net Income 53.83M
Sector Electronic Technology 2025 Sales Growth 3.303%
Fiscal Year-end 12 / 2026 Employees 3,000
View SEC Filings

NOVT Valuation

P/E Current 90.195
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) 81.133
Price to Sales Ratio 4.454
Price to Book Ratio 3.23
Price to Cash Flow Ratio 68.18
Enterprise Value to EBITDA 24.015
Enterprise Value to Sales 4.374
Total Debt to Enterprise Value 0.071

NOVT Efficiency

Revenue/Employee 326,866.667
Income Per Employee 17,943.00
Receivables Turnover 5.304
Total Asset Turnover 0.614

NOVT Liquidity

Current Ratio 3.685
Quick Ratio 2.799
Cash Ratio 1.793

NOVT Profitability

Gross Margin 41.587
Operating Margin 11.897
Pretax Margin 7.102
Net Margin 5.489
Return on Assets 3.369
Return on Equity 5.226
Return on Total Capital 3.329
Return on Invested Capital 3.887

NOVT Capital Structure

Total Debt to Total Equity 23.034
Total Debt to Total Capital 18.722
Total Debt to Total Assets 16.752
Long-Term Debt to Equity 19.308
Long-Term Debt to Total Capital 15.693
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Novanta - NOVT

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
860.90M 881.66M 949.25M 980.60M
Sales Growth
+21.80% +2.41% +7.67% +3.30%
Cost of Goods Sold (COGS) incl D&A
505.70M 499.77M 552.35M 572.79M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
53.16M 46.61M 55.56M 61.93M
Depreciation
13.55M 14.02M 15.00M 18.18M
Amortization of Intangibles
39.61M 32.60M 40.57M 43.75M
COGS Growth
+19.94% -1.17% +10.52% +3.70%
Gross Income
355.21M 381.90M 396.89M 407.81M
Gross Income Growth
+24.56% +7.51% +3.93% +2.75%
Gross Profit Margin
+41.26% +43.32% +41.81% +41.59%
2022 2023 2024 2025 5-year trend
SG&A Expense
244.67M 256.14M 271.46M 291.14M
Research & Development
85.77M 91.68M 95.52M 95.48M
Other SG&A
158.90M 164.46M 175.94M 195.66M
SGA Growth
+21.32% +4.69% +5.98% +7.25%
Other Operating Expense
- 3.07M 2.44M 1.14M
Unusual Expense
6.78M 15.31M 8.81M 20.55M
EBIT after Unusual Expense
100.68M 108.00M 115.48M 96.11M
Non Operating Income/Expense
2.10M 1.57M (4.93M) (5.00M)
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
15.62M 25.82M 31.49M 21.47M
Interest Expense Growth
+111.40% +65.33% +21.97% -31.81%
Gross Interest Expense
15.62M 25.82M 31.49M 21.47M
Interest Capitalized
- - - -
-
Pretax Income
87.16M 83.75M 79.07M 69.64M
Pretax Income Growth
+55.16% -3.91% -5.59% -11.92%
Pretax Margin
+10.12% +9.50% +8.33% +7.10%
Income Tax
13.11M 10.87M 14.98M 15.81M
Income Tax - Current - Domestic
65.00K 14.42M 43.00K 11.00K
Income Tax - Current - Foreign
31.70M 11.17M 30.85M 24.66M
Income Tax - Deferred - Domestic
- - - (12.22M)
-
Income Tax - Deferred - Foreign
(18.65M) (2.50M) (15.91M) (8.85M)
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
74.05M 72.88M 64.09M 53.83M
Minority Interest Expense
- - - -
-
Net Income
74.05M 72.88M 64.09M 53.83M
Net Income Growth
+47.13% -1.58% -12.06% -16.01%
Net Margin Growth
+8.60% +8.27% +6.75% +5.49%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
74.05M 72.88M 64.09M 53.83M
Preferred Dividends
- - - -
-
Net Income Available to Common
74.05M 72.88M 64.09M 53.83M
EPS (Basic)
2.0771 2.0332 1.7827 1.4712
EPS (Basic) Growth
+46.08% -2.11% -12.32% -17.47%
Basic Shares Outstanding
35.65M 35.84M 35.95M 36.59M
EPS (Diluted)
2.0622 2.0226 1.7741 1.4666
EPS (Diluted) Growth
+46.61% -1.92% -12.29% -17.33%
Diluted Shares Outstanding
35.91M 36.03M 36.12M 36.70M
EBITDA
160.62M 169.92M 179.86M 178.60M
EBITDA Growth
+28.02% +5.79% +5.85% -0.70%
EBITDA Margin
+18.66% +19.27% +18.95% +18.21%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 160.00
Number of Ratings 4 Current Quarters Estimate 0.86
FY Report Date 06 / 2026 Current Year's Estimate 3.563
Last Quarter’s Earnings 0.78 Median PE on CY Estimate N/A
Year Ago Earnings 3.29 Next Fiscal Year Estimate 4.047
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 3 3 3 3
Mean Estimate 0.86 0.92 3.56 4.05
High Estimates 0.89 0.93 3.61 4.10
Low Estimate 0.83 0.92 3.50 4.00
Coefficient of Variance 3.49 0.63 1.60 1.24

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 2 2 3
OVERWEIGHT 1 1 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Novanta - NOVT

Date Name Shares Transaction Value
Feb 27, 2026 Matthijs Glastra Chief Executive Officer; Director 75,008 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 Matthijs Glastra Chief Executive Officer; Director 69,761 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $137.44 per share 9,587,951.84
Feb 27, 2026 Matthijs Glastra Chief Executive Officer; Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 Robert John Buckley Chief Financial Officer 99,240 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 Robert John Buckley Chief Financial Officer 96,616 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $137.44 per share 13,278,903.04
Feb 27, 2026 Robert John Buckley Chief Financial Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 John Burke Chief Accounting Officer 9,041 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 John Burke Chief Accounting Officer 8,900 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $137.44 per share 1,223,216.00
Feb 27, 2026 John Burke Chief Accounting Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 Charles Guy Jr Ravetto Co-Chief Operating Officer 16,359 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
Feb 27, 2026 Charles Guy Jr Ravetto Co-Chief Operating Officer 16,116 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $137.44 per share 2,214,983.04
Feb 27, 2026 Charles Guy Jr Ravetto Co-Chief Operating Officer N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Novanta in the News